Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03718039 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Bunionectomy HTX-011 Administration Study
A Phase 2 study of Postoperative Pain, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT03718039 is a Phase 2 study of Postoperative Pain that has completed, run by Heron Therapeutics. The registered enrollment target is 78 participants, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03718039, a Phase 2 study of Postoperative Pain, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 2, open-label, multi-cohort study to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of a single, individualized dose of HTX-011 administered into the surgical site as a monotherapy or with other medications to enhance analgesia in subjects undergoing unilateral simple bunionectomy.
Conditions Studied
Interventions
- DRUG HTX-011
- DEVICE Luer Lock applicator
- DEVICE Vial access device
- DRUG aprepitant
Study Locations (1)
Texas
- Endeavor Clinical Trials, LLC - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2018-10-24 |
| Est. Completion | 2019-03-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03718039
The ClinicalTrials.gov registry entry for NCT03718039 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (66% lower). The listed sponsor is Heron Therapeutics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 4 interventions - of which HTX-011 is the first listed.
NCT03718039 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03718039 about?
NCT03718039 is a clinical study titled "Phase 2 Bunionectomy HTX-011 Administration Study". This is a Phase 2, open-label, multi-cohort study to evaluate the analgesic efficacy, safety, and pharmacokinetics (PK) of a single, individualized dose of HTX-011 administered into the surgical site as a monotherapy or with other medications to enhance analgesia in subjects undergoing unilateral si...
What is the current status of trial NCT03718039?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2018-10-24. Estimated completion is 2019-03-11.
What conditions does trial NCT03718039 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT03718039?
The interventions under investigation include: HTX-011 (DRUG), Luer Lock applicator (DEVICE), Vial access device (DEVICE), aprepitant (DRUG).
Who is sponsoring clinical trial NCT03718039?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03718039 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
-
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
RECRUITING · Phase 2
-
Effects of Oral Tranexamic Acid Following Total Knee Arthroplasty
RECRUITING · Phase 2
-
Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy
COMPLETED · Phase 2
-
Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy
COMPLETED · Phase 2
-
Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.